Yes, Cannabis Withdrawal Is Real. This 2004 Review Mapped What It Looks Like.
Review of the validity and significance of cannabis withdrawal syndrome
Bottom Line
A widely cited psychiatry review concluded that stopping heavy, long-term cannabis or THC use produces a consistent withdrawal syndrome and proposed diagnostic criteria.
Why It Matters
In 2004, many clinicians still questioned whether cannabis had a withdrawal syndrome at all. This review pulled together laboratory and clinical evidence showing a consistent pattern after cessation and offered a diagnostic framework that later shaped how health systems talk about cannabis-related problems.
The Backstory
For decades, the assertion was simple and widespread: cannabis doesn't cause withdrawal. Not like alcohol. Not like opioids. You can stop anytime and the worst you'll feel is a little bored. This was not fringe opinion — it was encoded in the DSM-IV, which did not include cannabis withdrawal as a diagnostic category. If the bible of psychiatry said cannabis withdrawal wasn't real, then it wasn't real.
Alan Budney, a clinical psychologist at the University of Vermont, knew the DSM-IV was wrong. He had been treating cannabis-dependent patients for years and watching them go through a predictable, reproducible set of symptoms every time they quit. In 2004, he published the review that would eventually change the diagnostic manual.
The Denial Problem
Cannabis withdrawal was not excluded from the DSM-IV because the evidence didn't exist. It was excluded because the evidence was scattered, the symptoms were considered "mild," and the comparison standard was alcohol and opioid withdrawal — syndromes that can be medically dangerous or fatal.
The politics of cannabis withdrawal diagnosis was complex. Admitting that cannabis causes physical withdrawal would strengthen the case that cannabis is "addictive" — a conclusion that neither the legalization movement nor the casual-use majority wanted to hear. Meanwhile, anti-drug advocates had cried wolf so many times about cannabis dangers that legitimate clinical observations were tainted by association.
Budney navigated this carefully. His co-author John Hughes was the leading authority on tobacco withdrawal — providing the methodological framework and the comparison that would prove critical. If tobacco withdrawal was clinically significant enough for the DSM (it was), and cannabis withdrawal was comparable in severity and functional impact (it was), then exclusion of cannabis withdrawal was scientifically indefensible.
Ryan Vandrey, another co-author, went on to become one of the most important cannabis pharmacology researchers at Johns Hopkins, continuing to build the evidence base that Budney established.
The Symptom Profile
Budney synthesized evidence from three lines of research: animal laboratory studies (CB1 knockout mice, THC withdrawal in rats), human laboratory studies (controlled abstinence on inpatient research units), and clinical reports from treatment-seeking cannabis users. The convergence across all three was striking.
The Time Course
The Comparison That Changed Everything
Budney's strategic masterstroke was the comparison to tobacco withdrawal. Nicotine withdrawal had been in the DSM since DSM-III. Nobody questioned its validity. And when Budney laid the two syndromes side by side, the similarities were impossible to ignore.
Comparable
Cannabis withdrawal severity was judged comparable to tobacco/nicotine withdrawal in magnitude, functional impairment, and role in relapse. Both syndromes are primarily emotional and behavioral. Both peak in the first week. Both drive relapse through craving and irritability. Neither is medically dangerous in the way alcohol or benzodiazepine withdrawal can be.
If tobacco withdrawal is clinically significant enough to be in the DSM — and it is — then cannabis withdrawal meets the same standard. The exclusion from DSM-IV was a logical inconsistency, not a scientific conclusion.
Budney et al. (2004); Hughes (2007) comparison framework
From Review to DSM-5
Budney didn't just review the evidence — he proposed specific diagnostic criteria. His proposed criteria closely matched what the DSM-5 eventually adopted nine years later in 2013:
Key Takeaways
The DSM-5 inclusion in 2013 was a watershed. It meant insurance could cover withdrawal management. It meant clinicians had a diagnostic code. It meant the millions of people who had experienced withdrawal symptoms after quitting cannabis were validated by the profession that had spent decades telling them their experience wasn't real.
What People Get Wrong
Myth vs. Reality
Cannabis withdrawal is just psychological — it's not physical like real withdrawal
Budney's review documented both emotional/behavioral and physical symptoms. Appetite loss, weight loss, headaches, stomach pain, sweating, chills, and tremor are physical symptoms. The distinction between 'psychological' and 'physical' withdrawal is itself misleading — all withdrawal is neurobiological. CB1 receptor rebound (documented by Hirvonen and D'Souza) is a physical process in the brain that produces both the emotional symptoms (anxiety, irritability) and the physical ones (sweating, appetite loss).
The Evidence
Budney et al. (2004); Hirvonen et al. (2012); D'Souza et al. (2016)
Myth vs. Reality
Cannabis withdrawal isn't dangerous, so it doesn't matter
It's true that cannabis withdrawal is not medically dangerous — unlike alcohol or benzodiazepine withdrawal, it won't kill you. But 'not dangerous' and 'not clinically significant' are different things. Withdrawal severity is the #1 predictor of relapse in people trying to quit cannabis. If withdrawal drives people back to problematic use, it matters — even if no one dies from the withdrawal itself.
The Evidence
Budney et al. (2004); subsequent relapse prediction studies
The Bigger Picture
Budney's 2004 review did something rare in medicine: it changed a diagnostic manual. The DSM-IV said cannabis withdrawal didn't exist. Budney's evidence showed it did. The DSM-5 agreed.
For anyone currently experiencing withdrawal, our complete withdrawal guide covers symptom management, and our day-by-day timeline tracks the typical course. For the neuroscience of what's happening during withdrawal, the Hirvonen and D'Souza studies explain the receptor dynamics. And for the question of whether cannabis is addictive more broadly, the Hasin 2015 study provides the population-level numbers.
Frequently Asked Questions
Cite this study
Budney, Alan J.; Hughes, John R.; Moore, Brent A.; Vandrey, Ryan. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161(11), 1967-1977. https://doi.org/10.1176/appi.ajp.161.11.1967